The bottom line:
- WHO recommends Tamiflu, but has not vetted the Tamiflu data.
- EMA approved Tamiflu, but did not review the full Tamiflu dataset.
- CDC and ECDC encourage the use and stockpiling of Tamiflu, but did not vet the Tamiflu data.
- The majority of Roche's Phase III treatment trials remain unpublished over a decade after completion.
- In Dec 2009, Roche publicly promised independent scientists access to "full study reports" for selected Tamiflu trials, but to date the company has not made even one full report available.
- http://www.bmj.com/tamiflu